Shandong Weigao Group Medical Polymer Company Limited (SHWGF)
- Previous Close
0.9575 - Open
0.9575 - Bid --
- Ask --
- Day's Range
0.9575 - 0.9575 - 52 Week Range
0.9575 - 1.7300 - Volume
25,000 - Avg. Volume
1,903 - Market Cap (intraday)
4.33B - Beta (5Y Monthly) 0.44
- PE Ratio (TTM)
11.97 - EPS (TTM)
0.0800 - Earnings Date --
- Forward Dividend & Yield 0.02 (2.23%)
- Ex-Dividend Date Jun 3, 2024
- 1y Target Est
--
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, wholesale, and sale of medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, specialized single-use clinical collection kits, digital products for clinical care, digestive nutrition, and primary care products; and general anesthesia consumables, local anesthesia consumables, anesthesia auxiliary consumables, ICU equipment, open and minimally invasive surgical equipment, wound healing dressings, wound suture, wound cleaning, and nonvascular catheter supporting extracorporeal devices. It also provides blood collection, irradiation, storage, separation, and sterilization products; blood collection and blood glucose testing devices; trauma, spinal implant, artificial joints, sports injury, soft tissue repair, reconstruction implant, orthopedic filling, and orthopedic related surgical tools; tumor intervention, vascular intervention, and interventional imaging; and prefilled syringes and pre-filled flush syringes. In addition, the company engages in the manufacturing of implantation materials and artificial organs; medical PVC granules, plastic packing bags, and carton boxes; industrial automatic equipment and parts; molds; hemodialysis equipment; and X-ray based irradiation machines. Further, it is involved in the finance leasing and factoring business; provision of asset management, enterprise consulting, enterprise management advisory services, logistics and storage, and computer technical services; and sale of electronic products. The company was incorporated in 2000 and is based in Weihai, the People's Republic of China.
www.weigaogroup.com12,519
Full Time Employees
December 31
Fiscal Year Ends
Sector
Medical Instruments & Supplies
Industry
Related News
Performance Overview: SHWGF
Trailing total returns as of 4/24/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SHWGF
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SHWGF
Valuation Measures
Market Cap
2.89B
Enterprise Value
2.45B
Trailing P/E
12.74
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
2.31
Price/Book (mrq)
1.41
Enterprise Value/Revenue
0.19
Enterprise Value/EBITDA
0.93
Financial Highlights
Profitability and Income Statement
Profit Margin
15.13%
Return on Assets (ttm)
4.08%
Return on Equity (ttm)
8.69%
Revenue (ttm)
13.23B
Net Income Avi to Common (ttm)
2B
Diluted EPS (ttm)
0.0800
Balance Sheet and Cash Flow
Total Cash (mrq)
7.33B
Total Debt/Equity (mrq)
17.38%
Levered Free Cash Flow (ttm)
--
Company Insights: SHWGF
SHWGF does not have Company Insights